Director Business Development Diagnostics Partnering at Thermo Fisher Scientific
Dr. Jürgen Doppke, received his PhD from the Ruhr University in Bochum in cooperation with Boehringer Ingelheim. Subsequently he gained 15 Years Experience in various Roles as Sales- and Product Specialist, Field Application Scientist and Product Line Leader for Lab Automation, Research Instrumentation and High Content Screening Products for Companies like Beckman Coulter, Molecular Devices and Perkin Elmer.
He joined Thermo Fisher Scientific in 2014 as Director, Business Development Diagnostics Partnering for Central Europe. In his current role he is responsible for partnerships with European Pharma Partners to develop Customized Diagnostics and Companion Diagnostics; leveraging existing IVD platforms with focus on targeted Next Gen Sequencing Panels and Liquid Biopsy for Oncology as well as Immunodiagnostics.
Title: Targeted Next Generation Sequencing Panels for the Rapid Development of CDx in Oncology
- A Universal Diagnostic for solid tumors
- NGS Panels for hematological Cancers
- NGS Panels for Immuno-Oncology Response
- Liquid Biopsy Panels